Related Experiment Video
Updated: Jun 20, 2026
Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain
Published on: July 24, 2016
Current Landscape of Neonatal/Infant HIV Research: Preclinical and Translational Perspectives
L M Johnson1, E H Luecke1, C A Norton1
1RTI International, Durham, North Carolina, USA.
Insights
Developing new long-acting antiretroviral formulations and immune-based interventions are key for pediatric HIV prevention and treatment. Preclinical studies in nonhuman primate models are crucial for advancing these strategies for children living with HIV.
Area of Science:
- Pediatric HIV Research
- Translational Science
- Nonhuman Primate (NHP) Models
Background:
- HIV significantly impacts neonatal and infant populations globally.
- Current treatment and prevention strategies require optimization for young children.
- Pediatric formulations for antiretroviral (ARV) drugs are a critical unmet need.
Purpose of the Study:
- To review outputs from a workshop focused on NHP models for pediatric HIV prevention and treatment.
- To highlight key strategies for advancing HIV interventions in children.
- To emphasize the role of preclinical research in developing pediatric formulations and immune-based interventions.
Main Methods:
- Review of workshop discussions and outputs.
- Focus on preclinical and translational research perspectives.
- Utilizing nonhuman primate (NHP) models for HIV research.
Main Results:
- Identified two primary strategies: novel long-acting (LA) ARV formulations and immune-based interventions.
- Highlighted the importance of NHP models in advancing these pediatric HIV strategies.
- Emphasized the translational value of preclinical studies for clinical application.
Conclusions:
- Advancing pediatric HIV treatment and prevention requires innovative approaches.
- Long-acting antiretroviral formulations offer potential for improved adherence and efficacy in children.
- Immune-based interventions show promise for preventing vertical HIV transmission.
- Nonhuman primate models are essential for the successful development and validation of pediatric HIV interventions.
Abstract:
This session of the NHP Models for HIV Prevention and Treatment: Towards Developing Pediatric Formulations workshop focused on preclinical and translational perspectives in HIV research, with an emphasis on neonatal and infant populations. This review described the outputs of this workshop session, highlighting two key strategies to advance HIV treatment and prevention in young children: the development of novel long-acting (LA) antiretroviral (ARV) formulations for children living with HIV (CLWH) and the implementation of immune-based interventions to prevent vertical HIV transmission. Both approaches demonstrate the critical importance and value of preclinical studies in nonhuman primate (NHP) models to support the advancement of these technologies, with the ultimate goal of improved health outcomes in pediatric populations.
